Protection of ischemic myocardium by exogenous phosphocreatine (neoton): pharmacokinetics of phosphocreatine, reduction of infarct size, stabilization of sarcolemma of ischemic cardiomyocytes, and antithrombotic action.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples